Inspire Medical Net Worth

Inspire Medical Net Worth Breakdown

  INSP
The net worth of Inspire Medical Systems is the difference between its total assets and liabilities. Inspire Medical's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Inspire Medical's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Inspire Medical's net worth can be used as a measure of its financial health and stability which can help investors to decide if Inspire Medical is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Inspire Medical Systems stock.

Inspire Medical Net Worth Analysis

Inspire Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Inspire Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Inspire Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Inspire Medical's net worth analysis. One common approach is to calculate Inspire Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Inspire Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Inspire Medical's net worth. This approach calculates the present value of Inspire Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Inspire Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Inspire Medical's net worth. This involves comparing Inspire Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Inspire Medical's net worth relative to its peers.

Enterprise Value

5.48 Billion

To determine if Inspire Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Inspire Medical's net worth research are outlined below:
Inspire Medical generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 624.8 M. Net Loss for the year was (21.15 M) with profit before overhead, payroll, taxes, and interest of 341.74 M.
Inspire Medical has a poor financial position based on the latest SEC disclosures
Over 98.0% of the company shares are owned by institutional investors
Latest headline from gurufocus.com: Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference
Inspire Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Inspire Medical Systems. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Inspire Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Inspire Medical Target Price Consensus

Inspire target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Inspire Medical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   16  Strong Buy
Most Inspire analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Inspire stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Inspire Medical Systems, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Inspire Medical Target Price Projection

Inspire Medical's current and average target prices are 198.68 and 239.60, respectively. The current price of Inspire Medical is the price at which Inspire Medical Systems is currently trading. On the other hand, Inspire Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Inspire Medical Market Quote on 4th of January 2025

Low Price190.36Odds
High Price202.04Odds

198.68

Target Price

Analyst Consensus On Inspire Medical Target Price

Low Estimate218.04Odds
High Estimate265.96Odds

239.6

Historical Lowest Forecast  218.04 Target Price  239.6 Highest Forecast  265.96
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Inspire Medical Systems and the information provided on this page.

Know Inspire Medical's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Inspire Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inspire Medical Systems backward and forwards among themselves. Inspire Medical's institutional investor refers to the entity that pools money to purchase Inspire Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Macquarie Group Ltd2024-09-30
582.3 K
Artisan Partners Limited Partnership2024-09-30
545.9 K
Hhg Plc2024-09-30
502.6 K
Geode Capital Management, Llc2024-09-30
483.7 K
Champlain Investment Partners, Llc2024-09-30
464.6 K
Aqr Capital Management Llc2024-09-30
446.4 K
Frontier Capital Management Co Inc2024-09-30
395 K
Ubs Asset Mgmt Americas Inc2024-09-30
365.2 K
Morgan Stanley - Brokerage Accounts2024-09-30
363.3 K
Vanguard Group Inc2024-09-30
3.2 M
Fmr Inc2024-09-30
2.9 M
Note, although Inspire Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Inspire Medical's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.95 B.

Market Cap

5.63 Billion

Project Inspire Medical's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.03)(0.03)
Return On Capital Employed(0.06)(0.06)
Return On Assets(0.03)(0.03)
Return On Equity(0.03)(0.03)
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.
When accessing Inspire Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Inspire Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Inspire Medical's profitability and make more informed investment decisions.

Evaluate Inspire Medical's management efficiency

Inspire Medical Systems has return on total asset (ROA) of 0.0118 % which means that it generated a profit of $0.0118 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0533 %, meaning that it created $0.0533 on every $100 dollars invested by stockholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of 01/04/2025, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.06. At this time, Inspire Medical's Total Current Liabilities is relatively stable compared to the past year. As of 01/04/2025, Liabilities And Stockholders Equity is likely to grow to about 817.2 M, while Non Current Liabilities Total is likely to drop slightly above 23.1 M.
Last ReportedProjected for Next Year
Book Value Per Share 17.58  18.46 
Tangible Book Value Per Share 17.58  18.46 
Enterprise Value Over EBITDA(390.99)(371.44)
Price Book Value Ratio 11.97  11.37 
Enterprise Value Multiple(390.99)(371.44)
Price Fair Value 11.97  11.37 
Enterprise Value5.2 B5.5 B
Leadership at Inspire Medical emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Enterprise Value Revenue
6.9929
Revenue
755.6 M
Quarterly Revenue Growth
0.325
Revenue Per Share
25.453
Return On Equity
0.0533
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inspire Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inspire Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Inspire Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Timothy Herbert over two months ago
Disposition of 3379 shares by Timothy Herbert of Inspire Medical at 206.19 subject to Rule 16b-3
 
John Rondoni over three months ago
Acquisition by John Rondoni of 5000 shares of Inspire Medical at 71.0 subject to Rule 16b-3
 
John Rondoni over three months ago
Disposition of 5000 shares by John Rondoni of Inspire Medical at 71.0 subject to Rule 16b-3
 
Ban Randy over three months ago
Disposition of 4861 shares by Ban Randy of Inspire Medical at 42.15 subject to Rule 16b-3
 
Ban Randy over three months ago
Disposition of 2350 shares by Ban Randy of Inspire Medical at 194.91 subject to Rule 16b-3
 
Shawn McCormick over three months ago
Disposition of 7518 shares by Shawn McCormick of Inspire Medical at 0.94 subject to Rule 16b-3
 
Melissa Mann over three months ago
Acquisition by Melissa Mann of 3190 shares of Inspire Medical subject to Rule 16b-3
 
Shelley Broader over three months ago
Acquisition by Shelley Broader of 117 shares of Inspire Medical at 138.58 subject to Rule 16b-3
 
Jerry Griffin over six months ago
Disposition of tradable shares by Jerry Griffin of Inspire Medical at 213.99 subject to Rule 16b-3
 
Sparks Charisse Y over six months ago
Disposition of tradable shares by Sparks Charisse Y of Inspire Medical subject to Rule 16b-3
 
Gary Ellis over six months ago
Acquisition by Gary Ellis of 716 shares of Inspire Medical subject to Rule 16b-3
 
Shawn McCormick over six months ago
Acquisition by Shawn McCormick of 716 shares of Inspire Medical subject to Rule 16b-3

Inspire Medical Corporate Filings

F4
23rd of December 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
12th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
4th of October 2024
An amended filing to the original Schedule 13G
ViewVerify
F3
1st of August 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
Inspire Medical time-series forecasting models is one of many Inspire Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Inspire Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Inspire Medical Earnings Estimation Breakdown

The calculation of Inspire Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Inspire Medical is estimated to be 0.331375 with the future projection ranging from a low of 0.3 to a high of 0.35. Please be aware that this consensus of annual earnings estimates for Inspire Medical Systems is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.6
0.30
Lowest
Expected EPS
0.331375
0.35
Highest

Inspire Medical Earnings Projection Consensus

Suppose the current estimates of Inspire Medical's value are higher than the current market price of the Inspire Medical stock. In this case, investors may conclude that Inspire Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Inspire Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2024Current EPS (TTM)
1713.78%
0.6
0.331375
1.17

Inspire Medical Earnings per Share Projection vs Actual

Actual Earning per Share of Inspire Medical refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Inspire Medical Systems predict the company's earnings will be in the future. The higher the earnings per share of Inspire Medical, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Inspire Medical Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Inspire Medical, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Inspire Medical should always be considered in relation to other companies to make a more educated investment decision.

Inspire Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Inspire Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-04
2024-09-300.080.60.52650 
2024-08-06
2024-06-30-0.140.320.46328 
2024-05-07
2024-03-31-0.65-0.340.3147 
2024-02-06
2023-12-31-0.090.490.58644 
2023-11-07
2023-09-30-0.58-0.290.2950 
2023-08-01
2023-06-30-0.57-0.410.1628 
2023-05-02
2023-03-31-0.66-0.530.1319 
2023-02-07
2022-12-31-0.570.10.67117 
2022-11-01
2022-09-30-0.77-0.60.1722 
2022-08-02
2022-06-30-0.62-0.530.0914 
2022-05-03
2022-03-31-0.8-0.610.1923 
2022-02-08
2021-12-31-0.44-0.090.3579 
2021-11-02
2021-09-30-0.61-0.380.2337 
2021-08-03
2021-06-30-0.64-0.480.1625 
2021-05-04
2021-03-31-0.66-0.60.06
2021-02-23
2020-12-31-0.48-0.280.241 
2020-11-02
2020-09-30-0.72-0.390.3345 
2020-08-04
2020-06-30-1.1-0.880.2220 
2020-05-05
2020-03-31-0.57-0.67-0.117 
2020-02-25
2019-12-31-0.4-0.380.02
2019-11-05
2019-09-30-0.41-0.340.0717 
2019-08-06
2019-06-30-0.43-0.320.1125 
2019-05-07
2019-03-31-0.38-0.350.03
2019-02-26
2018-12-31-0.31-0.220.0929 
2018-11-06
2018-09-30-0.35-0.220.1337 
2018-08-07
2018-06-30-0.51-0.430.0815 
2018-06-07
2018-03-31-3.64-5.05-1.4138 
2018-02-28
2017-12-310-3.46-3.46
2017-05-04
2017-03-310-3.9-3.9

Inspire Medical Corporate Directors

Georgia GarinoisMelenikiotouIndependent DirectorProfile
Megan CPADirector ReportingProfile
Shawn McCormickIndependent DirectorProfile
Jerry GriffinIndependent DirectorProfile

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.